×
About 5,045 results

ALLMedicine™ Lung Tumors Center

Research & Reviews  2,453 results

Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a n...
https://doi.org/10.21037/apm-20-1675
Annals of Palliative Medicine; Ying X, Ma N et. al.

Apr 9th, 2021 - The liver is one of the most common sites of metastatic spread of lung cancer, and the process of metastasis is regulated by many factors. A number of genes, including multiple tumor suppressor 1 (mts1), p120 catenin, and CT45A1, increase the poss...

The HILUS-trial - a prospective Nordic multi-center phase II study of ultra-central lun...
https://doi.org/10.1016/j.jtho.2021.03.019
Journal of Thoracic Oncology : Official Publication of Th... Lindberg K, Grozman V et. al.

Apr 6th, 2021 - Stereotactic body radiation therapy (SBRT) of thoracic tumors close to the central airways implies risk of severe toxicity. We report a prospective multicenter phase II trial for tumors located ≤1cm from the proximal bronchial tree (PBT) with prim...

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017108
Cancer Immunology, Immunotherapy : CII; Sangaletti S, Ferrara R et. al.

Apr 2nd, 2021 - Lung is a specialized tissue where metastases from primary lung tumors takeoff and those originating from extra-pulmonary sites land. One commonality characterizing these processes is the supportive role exerted by myeloid cells, particularly neut...

Glut1 expression in tumor-associated neutrophils promotes lung cancer growth and resist...
https://doi.org/10.1158/0008-5472.CAN-20-2870
Cancer Research; Ancey PB, Contat C et. al.

Mar 23rd, 2021 - Neutrophils are the most abundant circulating leucocytes and are essential for innate immunity. In cancer, pro- or anti-tumor properties have been attributed to tumor-associated neutrophils (TAN). Here, focusing on TAN accumulation within lung tum...

Primary BRAF Mutant Melanoma of the Lung Treated with Immunotherapy and Pulmonary Bilob...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985358
The American Journal of Case Reports; Bernal L, Restrepo J et. al.

Mar 18th, 2021 - BACKGROUND Primary melanoma of the lung is a rare tumor that represents 0.01% of primary lung tumors, with only 40 cases reported in the literature. Mucosal melanomas are tumors with a biological and clinical presentation that differs from that of...

see more →

Guidelines  1 results

Standards of practice: guidelines for thermal ablation of primary and secondary lung tu...
https://doi.org/10.1007/s00270-012-0340-1
Cardiovascular and Interventional Radiology; Pereira PL, Masala S et. al.

Jan 24th, 2012 - Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors.|2012|Pereira PL,Masala S,Salvatore M, ,|standards,diagnosis,pathology,secondary,surgery,diagnosis,pathology,secondary,surgery,diagnosis,pathology,secondar...

see more →

Clinicaltrials.gov  2,527 results

Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a n...
https://doi.org/10.21037/apm-20-1675
Annals of Palliative Medicine; Ying X, Ma N et. al.

Apr 9th, 2021 - The liver is one of the most common sites of metastatic spread of lung cancer, and the process of metastasis is regulated by many factors. A number of genes, including multiple tumor suppressor 1 (mts1), p120 catenin, and CT45A1, increase the poss...

The HILUS-trial - a prospective Nordic multi-center phase II study of ultra-central lun...
https://doi.org/10.1016/j.jtho.2021.03.019
Journal of Thoracic Oncology : Official Publication of Th... Lindberg K, Grozman V et. al.

Apr 6th, 2021 - Stereotactic body radiation therapy (SBRT) of thoracic tumors close to the central airways implies risk of severe toxicity. We report a prospective multicenter phase II trial for tumors located ≤1cm from the proximal bronchial tree (PBT) with prim...

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017108
Cancer Immunology, Immunotherapy : CII; Sangaletti S, Ferrara R et. al.

Apr 2nd, 2021 - Lung is a specialized tissue where metastases from primary lung tumors takeoff and those originating from extra-pulmonary sites land. One commonality characterizing these processes is the supportive role exerted by myeloid cells, particularly neut...

Glut1 expression in tumor-associated neutrophils promotes lung cancer growth and resist...
https://doi.org/10.1158/0008-5472.CAN-20-2870
Cancer Research; Ancey PB, Contat C et. al.

Mar 23rd, 2021 - Neutrophils are the most abundant circulating leucocytes and are essential for innate immunity. In cancer, pro- or anti-tumor properties have been attributed to tumor-associated neutrophils (TAN). Here, focusing on TAN accumulation within lung tum...

Primary BRAF Mutant Melanoma of the Lung Treated with Immunotherapy and Pulmonary Bilob...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985358
The American Journal of Case Reports; Bernal L, Restrepo J et. al.

Mar 18th, 2021 - BACKGROUND Primary melanoma of the lung is a rare tumor that represents 0.01% of primary lung tumors, with only 40 cases reported in the literature. Mucosal melanomas are tumors with a biological and clinical presentation that differs from that of...

see more →

News  61 results

Lorlatinib Surpasses Crizotinib as First-Line Treatment for Advanced ALK+ Lung Cancer
https://www.medscape.com/viewarticle/941249

Nov 18th, 2020 - NEW YORK (Reuters Health) - A comparison of two Pfizer anticancer drugs has concluded that lorlatinib produces more progression-free survival and is more effective against brain tumors as a first-line treatment than crizotinib in people with advan...

Molecular Signatures of Nonsmoking Lung Cancer in East Asians Identified
https://www.medscape.com/viewarticle/935346

Aug 9th, 2020 - NEW YORK (Reuters Health) - A comprehensive proteogenomic study of non-smoking lung cancer reveals molecular signatures of pathogenesis and progression, researchers in Taiwan report. Lung cancer is mainly attributed to direct tobacco exposure, but...

Antiangiogenics linked to fatal bleeds after RT in patients with “ultracentral” lung tumors
https://www.mdedge.com/chestphysician/article/201191/lung-cancer/antiangiogenics-linked-fatal-bleeds-after-rt-patients?channel=240
Andrew D. Bowser, MDedge News

May 18th, 2019 - In patients with tumors bordering the central airway, use of antiangiogenic agents has been linked to fatal hemorrhage after radiation treatment, according to investigators reporting a large, retrospective case series. Most hemorrhagic events in t.

Platinum-etoposide, taxanes best for small cell transformed EGFR-mutant lung cancer
https://www.mdedge.com/hematology-oncology/article/192620/lung-cancer/platinum-etoposide-taxanes-best-small-cell
Amy Karon

Jan 14th, 2019 - Epidermal growth factor receptor (EGFR)–mutant non–small cell lung tumors transformed to small cell disease an average of 17. 8 months after diagnosis, and this shift often involved Rb1, TP53, and PIK3CA mutations, according to the findings of a mu.

see more →

Patient Education  3 results see all →